Related Experiment Videos
Implantable dual-chamber cardioverter-defibrillator-pacemaker
D Pfeiffer1, M Mende, A Hagendorff
1Department of Cardiology, Angiology and Hemostaseology, Division of Internal Medicine, University of Leipzig, Johannisallee 32, D-04103 Leipzig, Germany. pfeid@medizin.uni-leipzig.de
Current Cardiology Reports
|August 23, 2000
Summary
Newer implantable cardioverter-defibrillators offer advanced dual-chamber pacing and arrhythmia detection. This review explores their benefits for ischemic heart disease, atrial fibrillation, and other pacing indications.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- The fifth generation of implantable cardioverter-defibrillators (ICDs) provides advanced features for arrhythmia management.
- Current consensus is lacking regarding optimal indications for dual-chamber pacemaker-defibrillator systems.
Purpose of the Study:
- To review the benefits of newer ICDs, focusing on four key areas.
- To discuss emerging indications, advantages, limitations, and future directions for dual-chamber systems.
Main Methods:
- Literature review of published data on newer dual-chamber ICDs.
- Focus on specific patient populations and device functionalities.
Main Results:
- Newer ICDs enhance detection of atrial and ventricular arrhythmias, offer antitachycardia pacing and shocks, and include comprehensive antibradycardia pacing.
- Potential benefits identified in permanent dual-chamber pacing for ischemic coronary disease and management of atrial fibrillation.
Conclusions:
- Dual-chamber ICD systems present evolving indications and functionalities.
- Further research is needed to establish definitive guidelines for their use in various patient groups.